000 | 03089 a2200409 4500 | ||
---|---|---|---|
999 |
_c26002 _d1399 |
||
001 | 26002 | ||
003 | TR-AnTOB | ||
005 | 20240927104042.0 | ||
008 | 161010bs2006 tu ka b 000 0 | ||
015 |
_aGBA601442 _2bnb |
||
016 |
_a013348527 _2Uk |
||
020 | _a0521858224 (hbk.) | ||
024 | _a9780521858229 (hbk.) | ||
035 | _a(OCoLC)OCM62475370 | ||
040 |
_aUKM _cUKM _dBAKER _dBWKUK _dOrLoB-B _dTR-AnTOB |
||
041 | _aeng | ||
060 |
_aQV 736 _bK73 2006 |
||
096 | _aQV736 K73 2006 | ||
245 | 0 | 0 |
_aKnowledge accumulation and industry evolution : _bthe case of Pharma-Biotech / _cedited by Mariana Mazzucato and Giovanni Dosi. |
264 | 1 |
_aCambridge, UK ; _aNew York : _bCambridge University Press, _c2006. |
|
300 |
_axvii, 446 p. : _bill. ; _c24 cm. |
||
336 |
_2rdacontent _atext _btxt |
||
337 |
_2rdamedia _aunmediated _bn |
||
338 |
_2rdacarrier _avolume _bnc |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 |
_g1. _g2. _g3. _g4. _g5. _g6. _g7. _g8. _g9. _g10. _g11. _g12. _g13. _g14. _rGiovanni Dosi and Mariana Mazzucato -- _rFrank R. Lichtenberg -- _rPaul Nightingale and Surya Mahdi -- _rMyriam Mariani -- _rLouis Galambos -- _rElena Cefis, Matteo Ciccarelli and Luigi Orsenigo -- _rGiulio Bottazzi, Fabio Pammolli and Angelo Secchi -- _rChristian Garavaglia, Franco Malerba and Luigi Orsenigo -- _rBoyan Jovanovic -- _rJohn P. Walsh, Ashish Arora and Wesley M. Cohen -- _rFabienne Orsi, Christine Sevilla and Benjamin Coriat -- _rPierre Regibeau and Katharine Rockett -- _rJoyce Tait, Joanna Chataway, Catherine Lyall and David Wield -- _rLuigi Orsenigo, Giovanni Dosi and Mariana Mazzucato. _tIntroduction / _tPharmaceutical innovation as a process of creative destruction / _tThe evolution of pharmaceutical innovation / _tFirm and regional determinants in innovation models : evidence from biotechnology and traditional chemicals / _tInnovation and industry evolution : a comment / _tHeterogeneity and firm growth in the pharmaceutical industry / _tGrowth and diversification patterns of the worldwide pharmaceutical industry / _tEntry, market structure, and innovation in a "history-friendly" model of the evolution of the pharmaceutical industry / _tThe growth of pharmaceutical firms : a comment / _tThe effects of research tool patents and licensing on biomedical innovation / _tUpstream patents and public health : the case of genetic testing for breast cancer / _tCompetition, regulation, and intellectual property management in genetically modified foods : evidence from survey data / _tGovernance, policy, and industry strategies : pharmaceuticals and agro-biotechnology / _tThe dynamics of knowledge accumulation, regulation, and appropriability in the pharma-biotech sector : policy issues / |
|
650 | 1 | 2 |
_aDrug Industry _923084 |
650 | 2 | 2 |
_aBiomedical Research _9128330 |
650 | 2 | 2 |
_aBiomedical Technology _9128329 |
650 | 2 | 2 |
_aTechnology, Pharmaceutical _923088 |
650 | 2 | 2 |
_aEconomics, Pharmaceutical _923086 |
700 |
_aMazzucato, Mariana, _d1968- _923082 |
||
700 |
_aDosi, Giovanni _923083 |
||
902 | _a0014629 | ||
942 |
_cBK _2NLM |